What are the treatment options for excessive sweating and hot flashes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Excessive Sweating and Hot Flashes

For individuals experiencing excessive sweating and hot flashes, the most effective pharmacological treatments include venlafaxine, paroxetine, and gabapentin, with selection based on symptom severity and individual patient factors. 1

First-Line Pharmacological Options

For Severe Hot Flashes:

  • Gabapentin: Effective at reducing hot flash frequency and severity by 46-49% at doses of 900 mg/day. Start with lower doses and titrate up. Side effects include somnolence and fatigue. 1

    • Mechanism: Acts through central temperature regulatory centers 1
    • Recommended for initial treatment in many cases due to efficacy and safety profile 1
  • SSRI/SNRI medications:

    • Venlafaxine: Significant reduction in both frequency and severity of hot flashes at doses of 37.5-75 mg. Common side effects include dry mouth, reduced appetite, nausea, and constipation. 1

      • Suggested starting dose: 37.5 mg with possible increase to 75 mg after one week if greater symptom control is needed 1
      • Particularly effective in breast cancer survivors taking tamoxifen 1
    • Paroxetine: Reduces hot flash composite scores by 62% (12.5 mg/day) to 65% (25 mg/day). Side effects include nausea, dizziness, and insomnia. 1

      • Optimal dose is 10-12.5 mg controlled release 1
      • Important caution: May interfere with tamoxifen metabolism in breast cancer patients 1

Treatment Algorithm Based on Symptom Severity

For Severe Hot Flashes:

  1. First option: Gabapentin (start at lower dose, target 900 mg/day)

    • Review for efficacy and side effects at 4-6 weeks 1
    • If intolerant or ineffective, switch to SSRI/SNRI
  2. Alternative first option: SSRI/SNRI (venlafaxine or paroxetine)

    • Review for efficacy and side effects at 2-4 weeks 1
    • For breast cancer patients on tamoxifen, prefer venlafaxine or citalopram over paroxetine or fluoxetine 1

For Mild to Moderate Hot Flashes:

  • Clonidine: Shows modest efficacy for hot flashes 1

    • Side effects include dry mouth, constipation, and drowsiness 1
  • Vitamin E: Consider high-dose (800 IU/day) for those with mild symptoms who prefer "natural" treatments 1

    • Caution: Doses >400 IU/day have been linked to increased all-cause mortality 1

Non-Pharmacological Approaches

  • Lifestyle modifications:

    • Dress in layers to allow for easy removal during hot flashes 1
    • Wear natural fibers 1
    • Use cold packs intermittently 1
    • Identify and avoid personal triggers (e.g., spicy food, hairdryers, anxiety) 1
    • Maintain healthy weight and stop smoking (hot flashes may be more severe in overweight women and smokers) 1
  • Behavioral interventions:

    • Paced respiration: Shown to reduce objectively measured hot flashes by approximately 50% with no adverse effects 2
    • Relaxation techniques: May provide benefit when properly structured 1
    • Hypnosis: Pilot studies show significant decreases in hot flash frequency and improvement in quality of life 1
  • Exercise: May improve quality of life, though direct effects on hot flashes show mixed results 1, 2

Special Considerations for Breast Cancer Patients

  • Avoid hormone replacement therapy (estrogen/progestin) as safety is not established in breast cancer survivors 1

  • Avoid black cohosh and other herbal supplements as they lack proven efficacy and may have safety concerns, including reports of liver failure with black cohosh 1

  • Consider medication interactions: Some SSRIs (particularly paroxetine and fluoxetine) may decrease the effectiveness of tamoxifen by inhibiting CYP2D6 enzyme. Prefer citalopram or venlafaxine in tamoxifen users 1

  • For male breast cancer patients: Management of endocrine therapy-related hot flashes is similar to approaches used for women, with venlafaxine showing effectiveness 1

Monitoring and Follow-up

  • Review pharmacological treatments for efficacy and side effects after 2-6 weeks (depending on medication) 1

  • Consider switching treatments if initial therapy is ineffective or poorly tolerated 1

  • Be aware that hot flashes may improve over time for many individuals 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.